Press release
Radiopharmaceutical Manufacturing Market Poised for Steady Growth at 5.0% CAGR Through 2031, Driven by Rising Demand for Advanced Nuclear Medicine
The global radiopharmaceutical manufacturing market is projected to reach US$9.6 billion by 2031, growing from US$6.8 billion in 2024 at a CAGR of 5.0% during the forecast period. This growth is primarily fueled by the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, which require advanced diagnostic imaging techniques like positron emission tomography (PET) and single photon emission computed tomography (SPECT).
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/34582
The technetium-99m (Tc-99m) segment is expected to dominate the market due to its widespread use in diagnostic imaging. North America remains the leading geographical region, accounting for the largest market share due to its advanced healthcare infrastructure, robust pharmaceutical industry, and significant investments in nuclear medicine.
Key Highlights from the Report
• The global radiopharmaceutical manufacturing market is expected to grow at a CAGR of 5.0% from 2024 to 2031.
• Increasing adoption of nuclear imaging techniques such as PET and SPECT is driving market expansion.
• Technetium-99m remains the leading radioisotope, widely used for diagnostic imaging.
• North America dominates the market due to advanced healthcare infrastructure and high adoption rates.
• The rising incidence of cancer and cardiovascular diseases is fueling demand for radiopharmaceuticals.
• Regulatory complexities and high production costs remain key challenges for market growth.
Market Segmentation
By Product Type
The radiopharmaceutical manufacturing market is segmented based on product type, including diagnostic and therapeutic radiopharmaceuticals. Technetium-99m continues to be the bestseller due to its widespread application in imaging. Fluorodeoxyglucose (FDG-PET) is another widely used diagnostic agent for detecting metabolic activity in tumors.
On the therapeutic side, radioisotopes such as Lutetium-177 and Yttrium-90 are gaining traction for targeted cancer treatments. These isotopes are used in radiopharmaceutical therapies such as peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors.
By End-User
Hospitals remain the largest consumers of radiopharmaceuticals, driven by the increasing number of diagnostic imaging procedures. Specialty clinics and diagnostic centers are also witnessing significant demand due to advancements in nuclear medicine and the availability of more precise imaging tools.
Regional Insights
North America: The Market Leader
North America holds the largest share in the radiopharmaceutical manufacturing market due to its strong nuclear medicine infrastructure, high healthcare expenditure, and presence of key industry players. The region's regulatory environment also supports innovations in radiopharmaceutical development, further strengthening market growth.
Asia-Pacific: Fastest Growing Region
Asia-Pacific is expected to witness the highest growth, with a projected CAGR of 5.4% through 2031. Factors contributing to this expansion include rising healthcare investments, increasing awareness of nuclear medicine, and growing demand for advanced imaging techniques in countries like China, India, and Japan.
Market Drivers
Rising Prevalence of Chronic Diseases
The increasing incidence of cancer, cardiovascular diseases, and neurological disorders is a primary driver of market growth. According to WHO, cancer was responsible for nearly 10 million deaths in 2020, highlighting the urgent need for early detection and treatment solutions.
Technological Advancements in Nuclear Imaging
Innovations in PET and SPECT imaging have enhanced the accuracy of disease diagnosis, boosting the demand for radiopharmaceuticals. The integration of artificial intelligence (AI) and machine learning in imaging systems is further optimizing nuclear medicine applications.
Growing Investment in Healthcare Infrastructure
Governments and private organizations are increasing investments in nuclear medicine facilities, particularly in emerging economies. This expansion is expected to improve accessibility to advanced radiopharmaceuticals for both diagnostic and therapeutic applications.
Market Restraints
Regulatory Challenges and High Production Costs
The radiopharmaceutical industry is heavily regulated due to stringent safety and quality standards. Obtaining approval from regulatory bodies such as the FDA and EMA is time-consuming, which slows down product commercialization.
Additionally, the high cost of production and limited availability of raw materials such as medical isotopes pose significant challenges. The reliance on nuclear reactors for isotope production further complicates supply chain dynamics.
Limited Awareness and Acceptance
Despite advancements in nuclear medicine, awareness and acceptance of radiopharmaceuticals remain low among patients and some healthcare providers. This lack of understanding can lead to hesitancy in adopting nuclear imaging techniques, affecting market penetration.
Market Opportunities
Expansion into Emerging Markets
The increasing healthcare investments in countries such as India, China, and Brazil present lucrative opportunities for radiopharmaceutical manufacturers. These regions are rapidly expanding their nuclear medicine infrastructure, driving demand for diagnostic and therapeutic radiopharmaceuticals.
Development of Personalized Radiopharmaceuticals
The shift toward precision medicine is fostering innovations in radiopharmaceuticals tailored to individual patient needs. Advances in molecular imaging and theranostics are expected to open new doors for targeted disease treatment, offering substantial growth potential.
Reasons to Buy the Report
✔ Comprehensive market analysis covering current trends and future outlook.
✔ Detailed segmentation based on product type, end-user, and geography.
✔ Insights into key growth drivers, restraints, and emerging opportunities.
✔ Competitive landscape analysis with key player profiles and recent developments.
✔ Regional insights highlighting market dynamics across major geographies.
Frequently Asked Questions (FAQs)
How Big is the Radiopharmaceutical Manufacturing Market?
Who are the Key Players in the Global Radiopharmaceutical Manufacturing Market?
What is the Projected Growth Rate of the Market?
What is the Market Forecast for 2032?
Which Region is Estimated to Dominate the Industry through the Forecast Period?
Company Insights
Key Players in the Market
GE Healthcare
Lantheus Holdings, Inc.
Cardinal Health
Bayer AG
Bracco Imaging S.p.A.
Curium Pharma
Siemens Healthineers
Jubilant Radiopharma
Recent Developments
Curium Pharma announced the expansion of its radiopharmaceutical production facilities in Europe to cater to the growing demand for nuclear medicine therapies.
Bayer AG launched a new targeted radiopharmaceutical therapy for prostate cancer, expanding its oncology portfolio.
Conclusion
The radiopharmaceutical manufacturing market is poised for steady growth, driven by advancements in nuclear imaging, rising prevalence of chronic diseases, and increasing healthcare investments worldwide. North America continues to lead the market, while Asia-Pacific presents significant expansion opportunities. Challenges such as regulatory hurdles and production costs persist, but ongoing innovations in personalized radiopharmaceuticals and theranostics are expected to shape the industry's future. As the demand for precise diagnostic and therapeutic solutions increases, the radiopharmaceutical sector is set to play a crucial role in modern healthcare advancements.
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com
About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceutical Manufacturing Market Poised for Steady Growth at 5.0% CAGR Through 2031, Driven by Rising Demand for Advanced Nuclear Medicine here
News-ID: 3924321 • Views: …
More Releases from Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Radiopharma
Nuclear Pharmacy Market Future Business Opportunities 2025-2032 | Curium Pharma, …
The Latest study titled Nuclear Pharmacy Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the report…
Actinium Pharmaceuticals (ATNM) Garners Attention with Clinical Successes and St …
Actinium's Chief Medical Officer, said, "In addition to demonstrating unprecedented 100% access to BMT in Iomab-B treated patients with active r/r AML and achieving the primary endpoint of dCR with high statistical significance, we are excited by the compelling outcomes in patients with a TP53 mutation in the SIERRA trial. We look forward to returning to EBMT and once again highlighting the positive results from the Phase 3 SIERRA trial…
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma A …
Biotech Stocks Taking Centerstage
As the pharmaceutical industry ventures deeper into the era of precision medicine, radiopharmaceuticals, particularly those involving alpha emitters like Actinium-225 (Ac-225), are gaining prominence for their targeted approach to cancer treatment. Amid this innovative surge, Actinium Pharmaceuticals (NYSE:ATNM) emerges not just as a company with a promising pipeline but as a beacon of cutting-edge manufacturing capabilities that could very well position it as a prime buyout candidate…
2030 Projections: Radiopharmaceutical Synthesizers Market to Deliver Dynamic Pro …
The Radiopharmaceutical Synthesizers Market Research Report 2023-2030 provides in-depth information on market trends, market capacity, industry size, growth factors, share, innovations, competitive environment, business problems, and more. This report's historical data confirms demand growth on a global, national, and regional scale. The studies on the global industry cover everything from comprehensive research to market size and forecasting to dynamics, growth factors, prospects, and hazards, as well as vendor knowledge. The…
Automated Radiosynthesis Modules Market Strategic Assessment & SWOT Analysis 202 …
An Informative report titled as Global Automated Radiosynthesis Modules Market has recently been published by Report Consultant to its online repository. This statistical data offers an in-depth analysis by considering several segments, such as type, size, technology and applications. Different exploratory techniques such as, qualitative and quantitative analysis have been used to give data accurately. For better understanding of the customers, it uses effective graphical presentation techniques, such as graphs,…
Cyclotron Market Growth Opportunities Analysis Report | GE Healthcare, Siemens H …
Cyclotron Market: Introduction
According to the report, the global cyclotron market was valued at US$ 215.5 Mn in 2019. It is projected to expand at a CAGR of ~3% from 2020 to 2030. Expansion activities of key radiopharma players; applications in clinical trials; increase in the geriatric population; pipeline assessment of new drugs; and disease indication mortality are major factors driving the cyclotron market. The shutdown of a few nuclear reactors has led to the…
